Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Follow-Up Study of HIV-1 Infected Adults Exiting a Parent Study Where EBT-101 Was Administered

NCT05143307 is registered in ClinicalTrials.gov with Excision BioTherapeutics as lead sponsor.

NCT NCT05143307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05143307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Follow-Up Study of HIV-1 Infected Adults Exiting a Parent Study Where EBT-101 Was Administered
Lead sponsor
Excision BioTherapeutics
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
July 11, 2023
Completion date
April 30, 2037
Enrollment
9 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection